CAS: 124937-51-5 - Phenol, 2-[(1R)-3-[bis(1-methylethyl)amino]-1-phenylpropyl]-4-methyl-
Formula:C22H31NO
InChI:InChI=1S/C22H31NO/c1-16(2)23(17(3)4)14-13-20(19-9-7-6-8-10-19)21-15-18(5)11-12-22(21)24/h6-12,15-17,20,24H,13-14H2,1-5H3/t20-/m1/s1
InChI key:InChIKey=OOGJQPCLVADCPB-HXUWFJFHSA-N
SMILES:OC1=CC=C(C=C1C(C=2C=CC=CC2)CCN(C(C)C)C(C)C)C
Tolterodine
CAS:124937-51-5
Tolterodine is a potent muscarinic receptor antagonists.
Formula:
C22H31NO
Purity:
98%
Color and Shape:
White Like Or Light Brown Crystalline Powder
Molecular weight:
325.49
Ref: TM-T23229
2mg | 63.00 € |
Estimated delivery in United States, on Wednesday 22 May 2024
Phenol, 2-[(1R)-3-[bis(1-methylethyl)amino]-1-phenylpropyl]-4-methyl-
CAS:124937-51-5
Formula:
C22H31NO
Purity:
98%
Color and Shape:
Solid
Molecular weight:
325.4876
Ref: AN-AG000MWB
5mg | 148.00 € |
Estimated delivery in United States, on Friday 24 May 2024
Tolterodine Tartrate
Formula:
C22H31NO·C4H6O6
Color and Shape:
White To Off-White Solid
Molecular weight:
325.50 150.09
Ref: 4Z-T-176
10mg | To inquire | |
25mg | To inquire | |
50mg | To inquire | |
100mg | To inquire |
Estimated delivery in United States, on Tuesday 28 May 2024
Ref: 4Z-T-1751
10mg | To inquire | |
25mg | To inquire | |
50mg | To inquire | |
100mg | To inquire |
Estimated delivery in United States, on Tuesday 28 May 2024
R-(+)-Tolterodine
CAS:124937-51-5
Applications A muscarinic receptor antagonist. Used in the treatment of urinary incontinence. References Nilvebrant, L., …
Formula:
C22H31NO
Color and Shape:
Pale Yellow Gel
Molecular weight:
325.49
Ref: TR-T535795
5mg | 229.00 € | |
10mg | 387.00 € | |
25mg | 866.00 € |
Estimated delivery in United States, on Friday 5 Jul 2024
R-(+)-Tolterodine
CAS:124937-51-5
Tolterodine is a drug that acts as a selective antagonist at the muscarinic receptor M3. …
Formula:
C22H31NO
Purity:
Min. 95%
Molecular weight:
325.49 g/mol
Ref: 3D-FT28311
2mg | To inquire | |
5mg | To inquire | |
10mg | To inquire | |
25mg | To inquire | |
50mg | To inquire |
Estimated delivery in United States, on Friday 5 Jul 2024